<?xml version='1.0' encoding='utf-8'?>
<document id="16733833"><sentence text="In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans."><entity charOffset="49-61" id="DDI-PubMed.16733833.s1.e0" text="indomethacin" /></sentence><sentence text="It was reported that the plasma concentration of indomethacin was increased with concomitant oral dosages of diflunisal in humans"><entity charOffset="49-61" id="DDI-PubMed.16733833.s2.e0" text="indomethacin" /></sentence><sentence text=" Both indomethacin and diflunisal are glucuronidated in humans"><entity charOffset="6-18" id="DDI-PubMed.16733833.s3.e0" text="indomethacin" /></sentence><sentence text=" The effects of diflunisal on the indomethacin glucuronidation were thus investigated in vitro using human liver microsomes (HLM) and human intestine microsomes (HIM) in order to assess the drug-drug interaction"><entity charOffset="34-46" id="DDI-PubMed.16733833.s4.e0" text="indomethacin" /></sentence><sentence text=" The glucuronidation of indomethacin in HLM showed atypical kinetics with Km and Ksi values of 210 and 89"><entity charOffset="24-36" id="DDI-PubMed.16733833.s5.e0" text="indomethacin" /></sentence><sentence text="5 microM, respectively, while HIM exhibited Michaelis-Menten kinetics with a Km value of 17" /><sentence text="4 microM" /><sentence text=" Diflunisal inhibited the indomethacin glucuronidation in HLM with IC50 values ranging from 100 to 231 microM"><entity charOffset="26-38" id="DDI-PubMed.16733833.s8.e0" text="indomethacin" /></sentence><sentence text=" In HIM, inhibition of the indomethacin glucuronidation by diflunisal was more potent with IC50 values of 15"><entity charOffset="27-39" id="DDI-PubMed.16733833.s9.e0" text="indomethacin" /></sentence><sentence text="2-48" /><sentence text="7 microM" /><sentence text=" When the clinical dose of diflunisal (250 mg b" /><sentence text="i" /><sentence text="d" /><sentence text=") is taken into consideration, it is expected that the diflunisal concentration in the intestine would be higher than the IC50 values for indomethacin glucuronidation in the intestine"><entity charOffset="138-150" id="DDI-PubMed.16733833.s15.e0" text="indomethacin" /></sentence><sentence text=" These findings suggest that the clinical drug-drug interaction between diflunisal and indomethacin may be at least partly attributable to the inhibition of indomethacin glucuronidation by diflunisal in the intestine"><entity charOffset="87-99" id="DDI-PubMed.16733833.s16.e0" text="indomethacin" /><entity charOffset="157-169" id="DDI-PubMed.16733833.s16.e1" text="indomethacin" /><pair ddi="false" e1="DDI-PubMed.16733833.s16.e0" e2="DDI-PubMed.16733833.s16.e0" /><pair ddi="false" e1="DDI-PubMed.16733833.s16.e0" e2="DDI-PubMed.16733833.s16.e1" /></sentence><sentence text="" /></document>